Literature DB >> 7783870

Trigeminal neuralgia in multiple sclerosis relieved by a prostaglandin E analogue.

A T Reder1, B G Arnason.   

Abstract

Trigeminal neuralgia is an uncommon but troublesome symptom of multiple sclerosis that can be refractory to conventional treatments. Misoprostol, a long-acting prostaglandin E1 analogue, relieved pain in six of seven patients who had failed to respond to conventional pharmacologic therapy.

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7783870     DOI： 10.1212/wnl.45.6.1097

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


  13 in total

Review 1.  Mechanisms of action of interferon-beta in multiple sclerosis.

Authors:  B G Arnason; A Dayal; Z X Qu; M A Jensen; K Genç; A T Reder
Journal:  Springer Semin Immunopathol       Date:  1996

Review 2.  Pharmacological management of pain in patients with multiple sclerosis.

Authors:  Claudio Solaro; Michele Messmer Uccelli
Journal:  Drugs       Date:  2010-07-09       Impact factor: 9.546

Review 3.  Multiple sclerosis: symptomatic treatment.

Authors:  A J Thompson
Journal:  J Neurol       Date:  1996-08       Impact factor: 4.849

Review 4.  Management of pain in multiple sclerosis: a pharmacological approach.

Authors:  Claudio Solaro; Michele Messmer Uccelli
Journal:  Nat Rev Neurol       Date:  2011-08-16       Impact factor: 42.937

Review 5.  Management of spasticity, pain, and paroxysmal phenomena in multiple sclerosis.

Authors:  R T Schapiro
Journal:  Curr Neurol Neurosci Rep       Date:  2001-05       Impact factor: 5.081

Review 6.  Pain and multiple sclerosis: pathophysiology and treatment.

Authors:  Claudio Solaro; Erika Trabucco; Michele Messmer Uccelli
Journal:  Curr Neurol Neurosci Rep       Date:  2013-01       Impact factor: 5.081

7.  Trigeminal neuralgia : a guide to drug choice.

Authors:  W P Cheshire
Journal:  CNS Drugs       Date:  1997-02       Impact factor: 5.749

Review 8.  How type I interferons work in multiple sclerosis and other diseases: some unexpected mechanisms.

Authors:  Anthony T Reder; Xuan Feng
Journal:  J Interferon Cytokine Res       Date:  2014-08       Impact factor: 2.607

Review 9.  Choosing drug therapy for multiple sclerosis. An update.

Authors:  B W van Oosten; L Truyen; F Barkhof; C H Polman
Journal:  Drugs       Date:  1998-10       Impact factor: 9.546

Review 10.  Current management of pain associated with multiple sclerosis.

Authors:  Walter Pöllmann; Wolfgang Feneberg
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.